/
NCT02504489_predicted_exclusion.ann
459 lines (459 loc) · 15.1 KB
/
NCT02504489_predicted_exclusion.ann
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
T1 Procedure 82 94 chemotherapy
T2 Procedure-Name 82 94 chemotherapy
T3 Procedure 97 110 immunotherapy
T4 Procedure-Name 97 110 immunotherapy
T5 Modifier 113 123 biological
T6 Modifier 126 134 targeted
T7 Procedure 140 157 radiation therapy
T8 Procedure-Name 140 157 radiation therapy
T9 Study 161 176 investigational
T10 Drug 177 182 agent
T11 Modifier 185 196 therapeutic
T12 Modifier 200 210 diagnostic
T13 Eq-Comparison 213 227 within 3 weeks
T14 Eq-Operator 213 219 within
T15 Eq-Value 220 221 3
T16 Eq-Temporal-Unit 222 227 weeks
T17 Study 248 253 study
T18 Drug 254 264 medication
T19 Severity 267 272 Major
T20 Procedure 273 280 surgery
T21 Procedure-Name 273 280 surgery
T22 Exception 283 293 other than
T23 Procedure 294 312 diagnostic surgery
T24 Procedure-Name 294 312 diagnostic surgery
T25 Eq-Comparison 315 329 within 4 weeks
T26 Eq-Operator 315 321 within
T27 Eq-Value 322 323 4
T28 Eq-Temporal-Unit 324 329 weeks
T29 Eq-Comparison 337 342 first
T30 Eq-Temporal-Recency 337 342 first
T31 Study 343 348 study
T32 Drug 349 353 drug
T33 Severity 376 387 Significant
T34 Condition 388 395 cardiac
T35 Eq-Comparison 396 403 history
T36 Eq-Temporal-Period 396 403 history
T37 Eq-Comparison 412 419 History
T38 Eq-Temporal-Period 412 419 History
T39 Condition 423 444 myocardial infarction
T40 Condition-Name 423 444 myocardial infarction
T41 Condition 448 470 ischemic heart disease
T42 Condition-Name 448 470 ischemic heart disease
T43 Eq-Comparison 471 484 within 1 year
T44 Eq-Operator 471 477 within
T45 Eq-Value 478 479 1
T46 Eq-Temporal-Unit 480 484 year
T47 Eq-Comparison 487 513 within a window of 18 days
T48 Eq-Operator 487 493 within
T49 Eq-Value 506 508 18
T50 Eq-Temporal-Unit 509 513 days
T51 Eq-Comparison 523 528 first
T52 Eq-Temporal-Recency 523 528 first
T53 Study 529 534 study
T54 Drug 535 539 drug
T55 Modifier 558 570 Uncontrolled
T56 Condition 571 581 arrhythmia
T57 Condition-Name 571 581 arrhythmia
T58 Eq-Comparison 585 592 History
T59 Eq-Temporal-Period 585 592 History
T60 Condition 596 622 congenital QT prolongation
T61 Condition-Name 596 622 congenital QT prolongation
T62 Procedure 626 629 ECG
T63 Procedure-Name 626 629 ECG
T64 Eq-Comparison 655 661 active
T65 Eq-Temporal-Period 655 661 active
T66 Condition 662 684 ischemic heart disease
T67 Condition-Name 662 684 ischemic heart disease
T68 Observation 688 714 New York Heart Association
T69 Observation-Name 688 714 New York Heart Association
T70 Eq-Comparison 715 730 Class III or IV
T71 Eq-Unit 715 720 Class
T72 Eq-Value 721 724 III
T73 Eq-Value 728 730 IV
T74 Condition 731 746 cardiac disease
T75 Condition-Name 731 746 cardiac disease
T76 Modifier 750 762 Uncontrolled
T77 Condition 763 775 hypertension
T78 Condition-Name 763 775 hypertension
T79 Observation 778 792 blood pressure
T80 Observation-Name 778 792 blood pressure
T81 Eq-Comparison 806 828 greater than 150 mm Hg
T82 Eq-Operator 806 818 greater than
T83 Eq-Value 819 822 150
T84 Eq-Unit 823 828 mm Hg
T85 Observation 829 837 systolic
T86 Eq-Comparison 842 851 100 mm Hg
T87 Eq-Value 842 845 100
T88 Eq-Unit 846 851 mm Hg
T89 Observation 852 861 diastolic
T90 Observation-Name 852 861 diastolic
T91 Drug 874 901 antihypertensive medication
T92 Drug-Name 874 901 antihypertensive medication
T93 Eq-Comparison 924 938 received prior
T94 Eq-Temporal-Period 924 938 received prior
T95 Procedure 939 948 treatment
T96 Drug 954 963 docetaxel
T97 Drug-Name 954 963 docetaxel
T98 Eq-Comparison 968 973 Prior
T99 Eq-Temporal-Period 968 973 Prior
T100 Condition 974 999 transient ischemic attack
T101 Condition-Name 974 999 transient ischemic attack
T102 Observation 1003 1027 cerebrovascular accident
T103 Observation-Name 1003 1027 cerebrovascular accident
T104 Eq-Comparison 1028 1048 within the past year
T105 Eq-Operator 1028 1034 within
T106 Eq-Temporal-Period 1039 1043 past
T107 Eq-Temporal-Unit 1044 1048 year
T108 Eq-Comparison 1051 1069 within an 18 - day
T109 Eq-Operator 1051 1057 within
T110 Eq-Value 1061 1063 18
T111 Eq-Temporal-Unit 1066 1069 day
T112 Observation 1085 1106 neurologic toxicities
T113 Observation-Name 1085 1106 neurologic toxicities
T114 Eq-Comparison 1107 1116 ≥ Grade 2
T115 Eq-Operator 1107 1108 ≥
T116 Eq-Unit 1109 1114 Grade
T117 Eq-Value 1115 1116 2
T118 Eq-Comparison 1117 1131 within 3 weeks
T119 Eq-Operator 1117 1123 within
T120 Eq-Value 1124 1125 3
T121 Eq-Temporal-Unit 1126 1131 weeks
T122 Study 1135 1148 randomization
T123 Eq-Comparison 1153 1160 History
T124 Eq-Temporal-Period 1153 1160 History
T125 Condition 1164 1184 hemorrhagic diarrhea
T126 Condition-Name 1164 1184 hemorrhagic diarrhea
T127 Condition 1187 1213 inflammatory bowel disease
T128 Condition-Name 1187 1213 inflammatory bowel disease
T129 Eq-Comparison 1217 1223 active
T130 Eq-Temporal-Period 1217 1223 active
T131 Modifier 1224 1236 uncontrolled
T132 Condition 1237 1257 peptic ulcer disease
T133 Condition-Name 1237 1257 peptic ulcer disease
T134 Procedure 1262 1281 Concomitant therapy
T135 Procedure-Name 1274 1281 therapy
T136 Drug 1287 1297 ranitidine
T137 Drug-Name 1287 1297 ranitidine
T138 Drug 1325 1335 omeprazole
T139 Drug-Name 1325 1335 omeprazole
T140 Eq-Comparison 1372 1379 History
T141 Eq-Temporal-Period 1372 1379 History
T142 Condition 1383 1388 ileus
T143 Other 1392 1397 other
T144 Severity 1398 1409 significant
T145 Condition 1410 1435 gastrointestinal disorder
T146 Condition-Name 1410 1435 gastrointestinal disorder
T147 Risk 1445 1455 predispose
T148 Condition 1459 1464 ileus
T149 Acuteness 1468 1475 chronic
T150 Procedure 1476 1494 bowel hypomotility
T151 Condition-Name 1476 1494 bowel hypomotility
T152 Eq-Comparison 1499 1505 Active
T153 Eq-Temporal-Period 1499 1505 Active
T154 Modifier 1506 1528 uncontrolled bacterial
T155 Modifier 1531 1536 viral
T156 Modifier 1542 1548 fungal
T157 Condition 1549 1558 infection
T158 Condition-Name 1549 1558 infection
T159 Assertion 1559 1568 requiring
T160 Procedure 1569 1585 systemic therapy
T161 Procedure-Name 1578 1585 therapy
T162 Condition 1596 1605 infection
T163 Condition-Name 1596 1605 infection
T164 Condition 1611 1639 human immunodeficiency virus
T165 Condition-Name 1611 1639 human immunodeficiency virus
T166 Condition 1642 1645 HIV
T167 Condition-Name 1642 1645 HIV
T168 Eq-Comparison 1651 1657 active
T169 Eq-Temporal-Period 1651 1657 active
T170 Condition 1658 1667 hepatitis
T171 Condition-Name 1658 1667 hepatitis
T172 Eq-Comparison 1691 1696 prior
T173 Eq-Temporal-Period 1691 1696 prior
T174 Condition 1697 1722 hypersensitivity reaction
T175 Condition-Name 1697 1722 hypersensitivity reaction
T176 Drug 1730 1763 product containing polysorbate 80
T177 Observation-Name 1730 1760 product containing polysorbate
T178 Eq-Value 1761 1763 80
T179 Drug 1766 1800 polyoxyethylene 15 hydroxystearate
T180 Modifier 1803 1830 Macrogol 15 hydroxystearate
T181 Modifier 1833 1840 Solutol
T182 Condition 1841 1843 HS
T183 Modifier 1849 1858 Kolliphor
T184 Condition 1859 1861 HS
T185 Condition-Name 1859 1861 HS
T186 Life-Stage-And-Gender 1871 1877 Female
T187 Condition 1893 1901 pregnant
T188 Condition-Name 1893 1901 pregnant
T189 Condition 1905 1914 lactating
T190 Condition-Name 1905 1914 lactating
T191 Eq-Comparison 1919 1925 Second
T192 Eq-Value 1919 1925 Second
T193 Condition 1926 1936 malignancy
T194 Condition-Name 1926 1936 malignancy
T195 Exception 1937 1943 unless
T196 Eq-Comparison 1961 1970 > 5 years
T197 Eq-Operator 1961 1962 >
T198 Eq-Value 1963 1964 5
T199 Eq-Temporal-Unit 1965 1970 years
T200 Negation 1975 1978 Non
T201 Modifier 1981 1994 melanoma skin
T202 Condition 1995 2001 cancer
T203 Condition-Name 1995 2001 cancer
T204 Condition 2005 2014 carcinoma
T205 Condition-Name 2005 2014 carcinoma
T206 Modifier 2030 2036 cervix
T207 Procedure 2037 2044 treated
T208 Procedure 2050 2065 curative intent
T209 Negation 2069 2072 not
T210 Condition 2096 2114 medical conditions
T211 Assertion 2154 2159 would
T212 Stability 2167 2176 excessive
T213 Risk 2177 2181 risk
T214 Condition 2216 2226 conditions
T215 Modifier 2235 2247 uncontrolled
T216 Condition 2248 2256 diabetes
T217 Condition-Name 2248 2256 diabetes
T218 Condition 2259 2268 infection
T219 Condition-Name 2259 2268 infection
T220 Assertion 2269 2278 requiring
T221 Procedure 2279 2316 parenteral anti - infective treatment
T222 Procedure-Name 2290 2316 anti - infective treatment
T223 Condition 2319 2332 liver failure
T224 Condition-Name 2319 2332 liver failure
T225 Condition 2339 2360 altered mental status
T226 Condition-Name 2339 2360 altered mental status
T227 Condition 2368 2389 psychiatric condition
T228 Condition-Name 2368 2389 psychiatric condition
T229 Stability 2401 2410 interfere
A1 Eq-Operator-Value T14 LTEQ
A2 Eq-Temporal-Unit-Value T16 week
A3 Severity-Value T19 severe
A4 Eq-Operator-Value T26 LTEQ
A5 Eq-Temporal-Unit-Value T28 week
A6 Eq-Temporal-Recency-Value T30 first-time
A7 Severity-Value T33 severe
A8 Eq-Temporal-Period-Value T36 past
A9 Eq-Temporal-Period-Value T38 past
A10 Eq-Operator-Value T44 LTEQ
A11 Eq-Temporal-Unit-Value T46 year
A12 Eq-Operator-Value T48 LTEQ
A13 Eq-Temporal-Unit-Value T50 day
A14 Eq-Temporal-Recency-Value T52 first-time
A15 Eq-Temporal-Period-Value T59 past
A16 Eq-Temporal-Period-Value T65 present
A17 Observation-Type-Value E37 clinical-score
A18 Observation-Type-Value E42 vital
A19 Eq-Operator-Value T82 GT
A20 Observation-Type-Value E44 vital
A21 Observation-Type-Value E46 vital
A22 Eq-Temporal-Period-Value T94 past
A23 Eq-Temporal-Period-Value T99 past
A24 Eq-Operator-Value T105 LTEQ
A25 Eq-Temporal-Period-Value T106 past
A26 Eq-Temporal-Unit-Value T107 year
A27 Eq-Operator-Value T109 LTEQ
A28 Eq-Temporal-Unit-Value T111 day
A29 Observation-Type-Value E56 lab
A30 Eq-Operator-Value T115 GTEQ
A31 Eq-Operator-Value T119 LTEQ
A32 Eq-Temporal-Unit-Value T121 week
A33 Eq-Temporal-Period-Value T124 past
A34 Eq-Temporal-Period-Value T130 present
A35 Eq-Temporal-Period-Value T141 past
A36 Severity-Value T144 severe
A37 Acuteness-Type-Value T149 chronic
A38 Eq-Temporal-Period-Value T153 present
A39 Assertion-Type-Value E81 hypothetical
A40 Eq-Temporal-Period-Value T169 present
A41 Eq-Temporal-Period-Value T173 past
A42 Life-Stage-And-Gender-Type T186 female
A43 Eq-Operator-Value T197 GT
A44 Eq-Temporal-Unit-Value T199 year
A45 Assertion-Type-Value E112 hypothetical
A46 Stability-Value T212 change
A47 Assertion-Type-Value E118 hypothetical
A48 Stability-Value T229 change
R1 Or Arg1:T1 Arg2:T3
R2 Or Arg1:T5 Arg2:T6
R3 Or Arg1:T6 Arg2:T7
R4 Or Arg1:T7 Arg2:T10
R5 Or Arg1:T11 Arg2:T12
R6 Before Arg1:T13 Arg2:T17
R7 Before Arg1:T25 Arg2:T29
R8 Before Arg1:T25 Arg2:T31
R9 Or Arg1:T39 Arg2:T41
R10 Before Arg1:T41 Arg2:T51
R11 Equivalent-To Arg1:T47 Arg2:T43
R12 Before Arg1:T43 Arg2:T51
R13 Before Arg1:T43 Arg2:T53
R14 Found-By Arg1:T66 Arg2:T62
R15 Equivalent-To Arg1:T79 Arg2:T77
R16 Equivalent-To Arg1:T85 Arg2:T77
R17 Equivalent-To Arg1:T85 Arg2:T79
R18 Or Arg1:T85 Arg2:T89
R19 Using Arg1:T95 Arg2:T96
R20 Or Arg1:T100 Arg2:T102
R21 Equivalent-To Arg1:T108 Arg2:T104
R22 Before Arg1:T118 Arg2:T122
R23 Or Arg1:T125 Arg2:T127
R24 Or Arg1:T127 Arg2:T132
R25 Using Arg1:T134 Arg2:T136
R26 Or Arg1:T142 Arg2:T145
R27 Caused-By Arg1:T147 Arg2:T145
R28 Or Arg1:T154 Arg2:T155
R29 Or Arg1:T155 Arg2:T156
R30 Treatment-For Arg1:T160 Arg2:T157
R31 And Arg1:T162 Arg2:T164
R32 Or Arg1:T162 Arg2:T170
R33 Abbrev-Of Arg1:T166 Arg2:T164
R34 Or Arg1:T166 Arg2:T170
R35 Caused-By Arg1:T174 Arg2:T176
R36 Caused-By Arg1:T174 Arg2:T179
R37 Or Arg1:T176 Arg2:T179
R38 Or Arg1:T179 Arg2:T180
R39 Equivalent-To Arg1:T182 Arg2:T180
R40 Equivalent-To Arg1:T184 Arg2:T180
R41 Or Arg1:T181 Arg2:T183
R42 Or Arg1:T182 Arg2:T184
R43 And Arg1:T186 Arg2:T187
R44 Or Arg1:T187 Arg2:T189
R45 Or Arg1:T202 Arg2:T204
R46 Treatment-For Arg1:T207 Arg2:T204
R47 Treatment-For Arg1:T208 Arg2:T204
R48 Using Arg1:T207 Arg2:T208
R49 Caused-By Arg1:T212 Arg2:T210
R50 Caused-By Arg1:T213 Arg2:T210
R51 Example-Of Arg1:T216 Arg2:T214
R52 Example-Of Arg1:T218 Arg2:T214
R53 Example-Of Arg1:T223 Arg2:T214
R54 Example-Of Arg1:T225 Arg2:T214
R55 Example-Of Arg1:T227 Arg2:T214
R56 Or Arg1:T216 Arg2:T218
R57 Treatment-For Arg1:T221 Arg2:T218
R58 Or Arg1:T221 Arg2:T223
R59 Or Arg1:T225 Arg2:T227
R60 Caused-By Arg1:T229 Arg2:T227
E1 Procedure:T1
E2 Procedure:T3
E3 Modifier:T5
E4 Modifier:T6
E5 Procedure:T7
E6 Study:T9 Study-Of:E7
E7 Drug:T10 Temporality:E10
E8 Modifier:T11
E9 Modifier:T12
E10 Eq-Comparison:T13
E11 Study:T17 Study-Of:E12
E12 Drug:T18
E13 Procedure:T20 Severity:T19
E14 Exception:T22 From:E13 Except:E15
E15 Procedure:T23
E16 Eq-Comparison:T25
E17 Eq-Comparison:T29
E18 Study:T31 Temporality:E17 Study-Of:E19
E19 Drug:T32 Temporality:E17
E20 Condition:T34 Severity:T33 Temporality:E21
E21 Eq-Comparison:T35
E22 Eq-Comparison:T37
E23 Condition:T39 Temporality:E22
E24 Condition:T41 Temporality:E25 Temporality:E26
E25 Eq-Comparison:T43
E26 Eq-Comparison:T47
E27 Eq-Comparison:T51
E28 Study:T53 Temporality:E27 Study-Of:E29
E29 Drug:T54 Temporality:E27
E30 Modifier:T55 Modifies:E31
E31 Condition:T56
E32 Eq-Comparison:T58
E33 Condition:T60 Temporality:E32
E34 Procedure:T62
E35 Eq-Comparison:T64
E36 Condition:T66 Temporality:E35
E37 Observation:T68 Numeric-Filter:E38
E38 Eq-Comparison:T70
E39 Condition:T74 Stage:E38
E40 Modifier:T76 Modifies:E41
E41 Condition:T77
E42 Observation:T79 Numeric-Filter:E43
E43 Eq-Comparison:T81
E44 Observation:T85 Numeric-Filter:E43 Numeric-Filter:E45
E45 Eq-Comparison:T86
E46 Observation:T89 Numeric-Filter:E45
E47 Drug:T91
E48 Eq-Comparison:T93
E49 Procedure:T95 Temporality:E48
E50 Drug:T96
E51 Eq-Comparison:T98
E52 Condition:T100 Temporality:E51
E53 Observation:T102 Temporality:E54 Temporality:E55
E54 Eq-Comparison:T104
E55 Eq-Comparison:T108
E56 Observation:T112 Numeric-Filter:E57 Temporality:E58
E57 Eq-Comparison:T114
E58 Eq-Comparison:T118
E59 Study:T122
E60 Eq-Comparison:T123
E61 Condition:T125 Temporality:E60
E62 Condition:T127
E63 Eq-Comparison:T129
E64 Modifier:T131 Modifies:E65
E65 Condition:T132 Temporality:E63
E66 Procedure:T134
E67 Drug:T136
E68 Drug:T138
E69 Eq-Comparison:T140
E70 Condition:T142 Temporality:E69 Severity:T144
E71 Other:T143 Is-Other:E72
E72 Condition:T145 Severity:T144
E73 Risk:T147 Risk-For:E74
E74 Condition:T148
E75 Procedure:T150
E76 Eq-Comparison:T152
E77 Modifier:T154 Modifies:E80
E78 Modifier:T155 Modifies:E80
E79 Modifier:T156 Modifies:E80
E80 Condition:T157 Temporality:E76
E81 Assertion:T159 Asserted:E82
E82 Procedure:T160
E83 Condition:T162
E84 Condition:T164
E85 Condition:T166
E86 Eq-Comparison:T168
E87 Condition:T170 Temporality:E86
E88 Eq-Comparison:T172
E89 Condition:T174 Temporality:E88
E90 Drug:T176
E91 Drug:T179
E92 Modifier:T180
E93 Modifier:T181 Modifies:E94
E94 Condition:T182
E95 Modifier:T183 Modifies:E96
E96 Condition:T184
E97 Condition:T187
E98 Condition:T189
E99 Eq-Comparison:T191
E100 Condition:T193 Minimum-Count:E99 Duration:E102
E101 Exception:T195 From:E100
E102 Eq-Comparison:T196
E103 Negation:T200 Negates:E104
E104 Modifier:T201 Modifies:E105
E105 Condition:T202
E106 Condition:T204
E107 Modifier:T206 Modifies:E106
E108 Procedure:T207
E109 Procedure:T208
E110 Negation:T209 Negates:E106 Negates:E108
E111 Condition:T210
E112 Assertion:T211 Asserted:T212 Asserted:E113
E113 Risk:T213 Stability:T212
E114 Condition:T214
E115 Modifier:T215 Modifies:E116
E116 Condition:T216
E117 Condition:T218
E118 Assertion:T220 Asserted:E119
E119 Procedure:T221
E120 Condition:T223
E121 Condition:T225
E122 Condition:T227